Neratinib (neratinib) listing price in China
Neratinib (Neratinib) is an oral, targeted therapy used to treat HER2-positive breast cancer, including early and advanced breast cancer. HER2 (human epidermal growth factor receptor 2) is a protein whose abnormal increase or overexpression is closely related to the development and progression of breast cancer. Neratinib (neratinib) blocks the growth and spread of tumor cells by inhibiting the HER2 receptor signaling pathway, thereby slowing down the progression of the disease.
Neratinib (neratinib) has now been launched in the domestic market and has been successfully included in the medical insurance system. Patients can purchase it domestically, with the price ranging from seven to eight thousand yuan. However, for final prices and medical insurance reimbursement details, please consult your local hospital pharmacy for accurate information. If you are looking for a more economical option, generic drugs produced in Bangladesh are a good alternative. The price is about more than 3,000 yuan, which is nearly half cheaper than the domestic market, and its drug ingredients are basically the same as the domestic version.

As a targeted therapy drug, Neratinib has a different mechanism of action from traditional chemotherapy drugs. It targets the specific growth signaling pathways of tumor cells, so it is relatively more effective and has fewer side effects. This makes neratinib (neratinib) an important treatment option, especially for patients with HER2-positive breast cancer.
Neratinib is usually taken as an oral medication at regular intervals each day, usually over a period of time. During use, patients need to receive regular monitoring and evaluation by doctors to ensure the effectiveness and safety of the treatment. In addition, doctors may adjust the dosage or take other treatment measures based on the patient's specific condition.
Although neratinib (neratinib) has shown good efficacy in the treatment of breast cancer, it may also cause some adverse reactions, such as diarrhea, nausea, vomiting, fatigue, etc. Therefore, patients need to pay close attention to their body reactions during use and report any discomfort or abnormalities to their doctor in a timely manner.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)